Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- Type: Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 8
- Coordinates: 9/24/2018, 10:30 - 12:00, Room 105
-
+
OA02.02 - Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC
10:40 - 10:50 | Presenter: Jessica Jiyeong Lin
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA02.03 - Clinical Activity of Lorlatinib in Patients with ROS1+ Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6
10:50 - 11:00 | Presenter: Sai-Hong Ignatius Ou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA04 - Novel Approaches with IO
- Type: Mini Oral Abstract Session
- Track: Immunooncology
- Presentations: 12
- Coordinates: 9/24/2018, 13:30 - 15:00, Room 107
-
+
MA04.03 - Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) with Oncogenic Driver Mutations: New Results from the Global IMMUNOTARGET Registry
13:40 - 13:45 | Presenter: Oliver Gautschi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA16 - Novel Mechanisms for Molecular Profiling
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
- Presentations: 12
- Coordinates: 9/25/2018, 13:30 - 15:00, Room 203 BD
-
+
MA16.05 - MET Kinase Domain Rearrangements (KDRE) in Non-Small Cell Lung Cancer (NSCLC) Identified Through Comprehensive Genomic Profiling (CGP)
14:00 - 14:05 | Author(s): Alexa B Schrock
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ES04 - Liquid Biopsies in Lung Cancer
- Type: Educational Session
- Track: Targeted Therapy
- Presentations: 6
- Coordinates: 9/25/2018, 15:15 - 16:45, Room 203 BD
-
+
ES04.00 - Introduction with Poll Questions
15:15 - 15:20 | Presenter: Sai-Hong Ignatius Ou
- Abstract
No abstract available for this presentation
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- Type: Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 8
- Coordinates: 9/25/2018, 15:15 - 16:45, Room 106
-
+
OA12.02 - Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer
15:25 - 15:35 | Presenter: Alexander Drilon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 45
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.13-46 - Comprehensive Investigation of ERBB2 Transmembrane Domain Mutations (V659/G660) in 12,833 Chinese Lung Cancer Patients
16:45 - 18:00 | Author(s): Ruoying Yu
- Abstract
Loading...